In order to translate cancer discovery into real benefits for an increasing number patients, VHIO adopts a purely translational, multidisciplinary research model. Organized into three main programs – Preclinical & Translational, Clinical, and Core Technologies, our research focuses on understanding the fundamental biology of human cancer, from cellular and molecular biology and genetics through to therapeutics.

Our optimal organizational structure allows VHIO talents to continue to both anticipate and tackle the many unresolved questions in ultimately outsmarting the multifaceted, heterogeneous and complex disease that is cancer: